EUVIMEDEUVIMED entdecken
Crossref

Enhanced oral absorption and anti-colorectal cancer efficacy of trifluridine by interfering with both TPase and UPase

Shulin Wan, Xinyi Fan, Peng Jin, Menghao Wei, Qianzhan Yang, Yinglan Yu, Hao Shao, Riyanto Teguh Widodo, Yaguang Wu, Lei Luo

Bioorganic Chemistry · 2026-09 · 180 · 110237

DOI: 10.1016/j.bioorg.2026.110237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-09. Verfasst von Shulin Wan und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China. Hauptthemen laut MEDLINE: Trifluridine, Colorectal Neoplasms, Antineoplastic Agents, Uridine Phosphorylase. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral nucleoside anticancer drugs are frequently limited by rapid enzymatic degradation, leading to inadequate systemic exposure and poor therapeutic efficacy. Trifluridine (FTD), a thymidine analogue used for metastatic colorectal cancer (CRC), is rapidly inactivated by thymidine phosphorylase (TPase) and uridine phosphorylase (UPase). Although the approved trifluridine/tipiracil (FTD/TPI) therapy protects FTD from TPase-mediated degradation, UPase remains insufficiently controlled. Uridine triacetate (TAU), a uridine prodrug, is used to sustain systemic uridine exposure and attenuate UPase-mediated FTD degradation. Here, we developed a dual-enzyme metabolic protection strategy for enhancing FTD exposure through TAU-mediated UPase and TPI-mediated TPase. The results indicated that uridine and FTD bound to the same UPase site, and elevated uridine exposure significantly increased oral FTD absorption. Among different TAU particle sizes, 200 μm slowed gastrointestinal release, generated maximal uridine exposure, and increased FTD absorption by 4.0-fold and 1.6-fold compared with FTD alone and FTD/TPI, respectively. Further, the combination of TPI and TAU achieved dual protection against UPase and TPase, maximized FTD exposure, and demonstrated favorable short-term safety. Notably, the half-dose FTD in combination with TAU and TPI achieved a systemic exposure comparable to that of full-dose FTD/TPI, indicating a potential dose-sparing effect. In colorectal cancer models, the combination markedly promoted anti-tumor efficacy through suppression of cell proliferation and induction of cell apoptosis. These findings establish a prodrug-enabled metabolic protection strategy for improving oral pharmacokinetics and therapeutic efficacy of metabolically vulnerable nucleoside anticancer drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrifluridineColorectal NeoplasmsAntineoplastic AgentsUridine PhosphorylaseThymidine PhosphorylaseHumansAnimalsAdministration, OralCell ProliferationUridineDose-Response Relationship, DrugDrug Screening Assays, AntitumorMolecular StructureMiceStructure-Activity RelationshipCell Line, Tumor

Stichwörter der Autor:innen

Colorectal cancerMetabolic protectionNucleoside phosphorylaseTipiracilTrifluridineUridine triacetate

Substanzen

TrifluridineAntineoplastic AgentsUridine PhosphorylaseThymidine PhosphorylaseUridine

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
  • College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China; The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
  • Analytical Instruments Department, Analytical Applications Center, Shimadzu (China) Co., Ltd. Chongqing Branch, Chongqing 404100, China.
  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
  • Department of Dermatology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China. Electronic address: wuyaguangcq@tmmu.edu.cn.
  • College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China. Electronic address: drluolei@swu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wan, S., Fan, X., Jin, P., Wei, M., Yang, Q., Yu, Y., Shao, H., Widodo, R. T., Wu, Y., & Luo, L. (2026). Enhanced oral absorption and anti-colorectal cancer efficacy of trifluridine by interfering with both TPase and UPase. Bioorganic Chemistry, 180, 110237. https://doi.org/10.1016/j.bioorg.2026.110237

Vancouver

Wan S, Fan X, Jin P, Wei M, Yang Q, Yu Y, et al. Enhanced oral absorption and anti-colorectal cancer efficacy of trifluridine by interfering with both TPase and UPase. Bioorganic Chemistry. 2026;180:110237. doi:10.1016/j.bioorg.2026.110237

BibTeX
@article{Wan2026,
  author = {Wan, Shulin and Fan, Xinyi and Jin, Peng and Wei, Menghao and Yang, Qianzhan and Yu, Yinglan and Shao, Hao and Widodo, Riyanto Teguh and Wu, Yaguang and Luo, Lei},
  title = {Enhanced oral absorption and anti-colorectal cancer efficacy of trifluridine by interfering with both TPase and UPase},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {180},
  pages = {110237},
  doi = {10.1016/j.bioorg.2026.110237}
}
Kostenlos starten →